Arbeitspapier
Big pharma and monopoly capitalism: A long-term view
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect intellectual monopolies rather than an incentive and a reward to innovative efforts. Patenting strategies appear to be quite aggressive in extending knowledge borders and enlarging the space protected from the possibility of infringements. This is also witnessed by the fact that patent applications are very skewed in the covered trade names and patent thickness expands over time. Conversely, the number of patents protecting new drugs approved by the FDA which draw upon government-sponsored research - as such a mark for quality - falls. Firm-level analysis on profitability confirms strong correlation, restricted to listed pharmaceutical firms, between patent portfolio and profit margins.
- Sprache
-
Englisch
- Erschienen in
-
Series: LEM Working Paper Series ; No. 2021/26
- Klassifikation
-
Wirtschaft
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Innovation and Invention: Processes and Incentives
Intellectual Property and Intellectual Capital
- Thema
-
Intellectual property rights
patents
pharmaceutical industry
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Dosi, Giovanni
Marengo, Luigi
Staccioli, Jacopo
Virgillito, Maria Enrica
- Ereignis
-
Veröffentlichung
- (wer)
-
Scuola Superiore Sant'Anna, Laboratory of Economics and Management (LEM)
- (wo)
-
Pisa
- (wann)
-
2021
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Dosi, Giovanni
- Marengo, Luigi
- Staccioli, Jacopo
- Virgillito, Maria Enrica
- Scuola Superiore Sant'Anna, Laboratory of Economics and Management (LEM)
Entstanden
- 2021
Ähnliche Objekte (12)
The agenda for evolutionary economics: Results, dead ends, and challenges ahead
Statistical regularities in the evolution of industries: A guide through some evidence and challenges for the theory
Finance, Innovation and Corporate Change
Technological innovation, institutions and human purposefulness in socioeconomic evolution: A preface to Christopher Freeman "System of innovation. Selected essays in evolutionary economics"
Policy Lessons From Medical Responses to the COVID-19 Crisis
A very reasonable objective still beyond our reach: Economics as an empirically disciplined social science
Some policy lessons from medical/therapeutic responses to the COVID-19 crisis: A rich research system for knowledge generation and dysfunctional institutions for its exploitation
Economic coordination and dynamics: Some elements of an alternative "evolutionary" paradigm
Technological catching-up, sales dynamics and employment growth: evidence from China’s manufacturing firms
Local and divergent patterns of technological learning within (partly) globalized markets: Is there anything new? And what can policies do about it? A concise guide
The "Schumpeterian" and the "Keynesian" Stiglitz: Learning, coordination hurdles and growth trajectories
The grip of history and the scope for novelty: Some results and open questions on path dependence in economic processes
The agenda for evolutionary economics: Results, dead ends, and challenges ahead
Statistical regularities in the evolution of industries: A guide through some evidence and challenges for the theory
Finance, Innovation and Corporate Change
Technological innovation, institutions and human purposefulness in socioeconomic evolution: A preface to Christopher Freeman "System of innovation. Selected essays in evolutionary economics"
Policy Lessons From Medical Responses to the COVID-19 Crisis
A very reasonable objective still beyond our reach: Economics as an empirically disciplined social science
Some policy lessons from medical/therapeutic responses to the COVID-19 crisis: A rich research system for knowledge generation and dysfunctional institutions for its exploitation
Economic coordination and dynamics: Some elements of an alternative "evolutionary" paradigm
Technological catching-up, sales dynamics and employment growth: evidence from China’s manufacturing firms
Local and divergent patterns of technological learning within (partly) globalized markets: Is there anything new? And what can policies do about it? A concise guide
The "Schumpeterian" and the "Keynesian" Stiglitz: Learning, coordination hurdles and growth trajectories
The grip of history and the scope for novelty: Some results and open questions on path dependence in economic processes
The agenda for evolutionary economics: Results, dead ends, and challenges ahead
Statistical regularities in the evolution of industries: A guide through some evidence and challenges for the theory
Finance, Innovation and Corporate Change
Technological innovation, institutions and human purposefulness in socioeconomic evolution: A preface to Christopher Freeman "System of innovation. Selected essays in evolutionary economics"
Policy Lessons From Medical Responses to the COVID-19 Crisis
A very reasonable objective still beyond our reach: Economics as an empirically disciplined social science
Some policy lessons from medical/therapeutic responses to the COVID-19 crisis: A rich research system for knowledge generation and dysfunctional institutions for its exploitation
Economic coordination and dynamics: Some elements of an alternative "evolutionary" paradigm
Technological catching-up, sales dynamics and employment growth: evidence from China’s manufacturing firms
Local and divergent patterns of technological learning within (partly) globalized markets: Is there anything new? And what can policies do about it? A concise guide
The "Schumpeterian" and the "Keynesian" Stiglitz: Learning, coordination hurdles and growth trajectories